The phospholipid composition of various strains of the yeast, Saccharomyces cerevisiae, and several of their derived mitochondrial mutants grown under conditions designed to induce variations in the complement of mitochondrial membranes has been examined. Wild type and petite (cytoplasmic respiratory deficient) yeasts were fractionated into various subcellular fractions, which were monitored by electron microscopy and analyzed for cytochrome oxidase (in wild type) and phospholipid composition. 90% or more of the phospholipid, cardiolipin was found in the mitochondrial membranes of wild type and petite yeast. Cardiolipin content differed markedly under various growth conditions. Stationary yeast grown in glucose had better developed mitochondria and more cardiolipin than repressed log phase yeast. Aerobic yeast contained more cardiolipin than anaerobic yeast. Respiration-deficient cytoplasmic mitochondrial mutants, both suppressive and neutral, contained less cardiolipin than corresponding wild types. A chromosomal mutant lacking respiratory function had normal cardiolipin content. Log phase cells grown in galactose and lactate, which do not readily repress the development of mitochondrial membranes, contained as much cardiolipin as stationary phase cells grown in glucose. Cytoplasmic mitochondrial mutants respond to changes in the glucose concentration of the growth medium by variations in their cardiolipin content in the same way as wild type yeast does under similar growth conditions. It is concluded that cardiolipin content of yeast is correlated with, and is a good indicator of, the state of development of mitochondrial membrane.
Skip Nav Destination
Article navigation
1 March 1971
Article|
March 01 1971
CARDIOLIPIN CONTENT OF WILD TYPE AND MUTANT YEASTS IN RELATION TO MITOCHONDRIAL FUNCTION AND DEVELOPMENT
S. Jakovcic,
S. Jakovcic
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
Search for other works by this author on:
G. S. Getz,
G. S. Getz
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
Search for other works by this author on:
M. Rabinowitz,
M. Rabinowitz
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
Search for other works by this author on:
H. Jakob,
H. Jakob
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
Search for other works by this author on:
H. Swift
H. Swift
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
Search for other works by this author on:
S. Jakovcic
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
G. S. Getz
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
M. Rabinowitz
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
H. Jakob
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
H. Swift
From the Departments of Biochemistry, Pathology, Medicine, and Biology, Pritzker School of Medicine, The University of Chicago, and the Argonne Cancer Research Hospital (operated by The University of Chicago for the United States Atomic Energy Commission), Chicago, Illinois 60637, and the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, 91 Gif-sur-Yvette, France.
Dr. Jakob's present address is The Institut Pasteur, Paris, France.
Received:
May 25 1970
Revision Received:
October 19 1970
Online ISSN: 1540-8140
Print ISSN: 0021-9525
Copyright © 1971 by The Rockefeller University Press
1971
J Cell Biol (1971) 48 (3): 490–502.
Article history
Received:
May 25 1970
Revision Received:
October 19 1970
Citation
S. Jakovcic, G. S. Getz, M. Rabinowitz, H. Jakob, H. Swift; CARDIOLIPIN CONTENT OF WILD TYPE AND MUTANT YEASTS IN RELATION TO MITOCHONDRIAL FUNCTION AND DEVELOPMENT . J Cell Biol 1 March 1971; 48 (3): 490–502. doi: https://doi.org/10.1083/jcb.48.3.490
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement